Capital Markets: Debt & Equity (PRC Firms)
China
4 years ranked
Capital Markets: Debt & Equity (PRC Firms)
China
4 years ranked
Provided by Jia Yuan Law Offices
Domestic financing services | M&A transactions | Overseas financing services
Lawyer qualification,2007 China, 2007
Member of the Shanghai Huangpu District Young Entrepreneurs Association
Member of the Securities Business Research Committee of the Shanghai Lawyers Association
Lawyer Fu Yangyuan is responsible for leading various non-litigation projects. These projects include: Huaitai Medical’s IPO on the Sci-Tech Innovation Board, Aihong Medicine’s IPO on the Sci-Tech Innovation Board, Rende Biology’s IPO on the Sci-Tech Innovation Board, Hongbo Medicine’s IPO on the ChiNext Board, Nuocheng Jianhua’s IPO on the Sci-Tech Innovation Board, Jingchen Shares’ IPO on the Sci-Tech Innovation Board, Jianghang Equipment’s IPO on the Sci-Tech Innovation Board, Guangyun Technology’s IPO on the Sci-Tech Innovation Board, Shengtai Group’s A-share IPO, Rihuo Rongmei’s IPO on the ChiNext Board, Shanghai Kaixin’s IPO on the ChiNext Board, MicroPort Medical’s division of MicroPort Robotics’ H-share IPO, MicroPort Medical’s division of MicroPort Brain Science’s Hong Kong IPO, TEG Medicine’s division of Fangda Holdings’ Hong Kong IPO, TEG Medicine’s H-share and A-share ChiNext IPO, Quanfeng Automobile’s A-share IPO, Huamao Logistics’ A-share IPO, Senma Clothing’s A-share IPO, Aojiahua’s A-share IPO, Haitong Securities’ division of Haitong Hengxin’s H-share IPO, Kangdelei’s division of Kangdelei Medical Devices’ H-share IPO, Huaizhen Medical’s Hong Kong IPO, and Guoyao Holdings’ H-share IPO.IPO projects, Junshi Biotech's additional share issuance in 2022, Shangchai Co., Ltd.'s major asset restructuring project, Huachangda's major asset restructuring project in 2014, Shenyang Lan Ying's acquisition of the industrial cleaning systems and surface treatment business of the German company Dürr Group, Zhejiang Fu Holdings' private issuance project in 2013, SAIC Group's private issuance project in 2016, Huayu Automotive's private issuance project, Hemudan's private issuance project, Taige Medicine's private issuance project, Spring Airlines' private issuance project, and Aojia Hua's public issuance project for convertible corporate bonds. Additionally, Lawyer Fu Yangyuan has also served as the senior legal counsel for many private equity investment projects involving 杉木资本、Qiming Venture Capital, Zhongxin Juyuan, Hengxu Capital, and Yingke Capital. Furthermore, Lawyer Fu Yangyuan is also the senior legal counsel for A-share and H-share listed companies such as SAIC Group, Huayu Automotive, Taige Medicine, Junshi Biotech, Aihong Medicine, Jingchen Shares, Jianghang Equipment, Microbot Robotics, Haitong Hengxin, Wangbian Electric, Shengtai Garments, Aojia Hua, and Lan Ying Equipment.
CEIBS European International Business School
currently pursuing an EMBA program
Shanghai University of Finance and Economics
Master of Law
2018
Wuhan University of Technology
Bachelor of Law
2005
Huazhong University of Science and Technology
Bachelor of Arts
2005
Chinese, English
Provided by Chambers
Provided by Chambers
Her service is professional and pragmatic. She has rich experience in handling complex legal relationships and strong business thinking.
她的服务专业务实,在处理复杂的法律关系方面经验丰富,且具备敏锐的商业思维。
Chambers is the leading data and intelligence partner for the legal sector.